Stock listing
Odyssey Therapeutics, Inc.
Selected listing: ODTX · NASDAQ · USD · US
Odyssey Therapeutics, Inc. (NASDAQ:ODTX), Health Technology. Latest release Oct 6, 2026: Odyssey Therapeutics Announces Oral Presentation of Additional Phase…
- Ticker
- NASDAQ:ODTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. (ticker: ODTX) is a public company operating in the American market. The company is committed to advancing its research and development efforts to address unmet medical needs.
Latest news from Odyssey Therapeutics, Inc.
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
October 5, 2026
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
October 6, 2026
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
September 16, 2026
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
August 26, 2026
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 4, 2026
Research Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. company profile
View the public company page for Odyssey Therapeutics, Inc. on 6ix.
Odyssey Therapeutics, Inc. news
Read company news and market updates connected to Odyssey Therapeutics, Inc..
Odyssey Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Odyssey Therapeutics, Inc..